University of California, Irvine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Irvine sits in the top decile of US sponsors by registered trial count (#96 of 15,742 sponsors by registered trial count).
University of California, Irvine: 368 sponsored US clinical trials, 74 recruiting.
University of California, Irvine sponsors 368 registered US clinical trials on ClinicalTrials.gov, 74 of them currently recruiting, and 228 completed. 27 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 6 trials.
Top-decile sponsor footprint
University of California, Irvine ranks in the top decile of sponsors by registered trial count (#96 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
228 of 258 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
368 total, page 7 of 8
Robotic-assisted Laparoscopic Sacrocolpopexy
NCT00581334
Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet
NCT00585650
Effects of PRK 124 Lotion in Acne Rosacea
NCT00580723
Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
NCT00573729
Use of Diffuse Optical Spectroscopy for Evaluation of the Trauma/Critically Care Patients
NCT00581295
LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis
NCT00573365
Fractional Resurfacing Device for Treatment of Acne Scarring
NCT00585286
Molecular Urine Tests for Prostate Cancer
NCT00581516
Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.
NCT00556309
A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
NCT00556114
Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)
NCT00254072
Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort
NCT00786721
Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
NCT00585247
Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
NCT00610467
Robotics For Rehabilitation Therapy: Functional Versus Individual Joint Training
NCT01050231
Muscle Pressure in the Flank Position
NCT00395980
Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
NCT00585715
Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases
NCT00786539
The Reinforcing Mechanisms of Smoking in Adult ADHD
NCT00573859
A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery
NCT00581399
Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy
NCT00571116
Beta-hCG + Erythropoietin in Acute Stroke
NCT00362414
Effectiveness of Cranberry Ingestion on Bacterial Adhesion: An Adjunct Study
NCT00506025
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab
NCT00319839
Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus
NCT00613886
Monitoring Functional Variation in the Breast During Menstrual Cycle by Using Diffuse Optical Spectroscopy
NCT00540306
Brain Dopamine Function in Adults With ADHD
NCT00580814
Understanding and Improving Diabetes Care for Ethnic Minorities
NCT01123239
Traditional vs. Graft-augmented Posterior Colporrhaphy
NCT00581594
Chart Review of Laparoscopic Radical Cystectomy
NCT00393601
Neoadjuvant Treatment of Breast Cancer
NCT00254592
Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database
NCT00593411
Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains
NCT00556946
Nicotine and Behavior in Adult ADHD
NCT00573248
Resveratrol for Patients With Colon Cancer
NCT00256334
Optical Coherence Tomography of the Gastrointestinal Tract
NCT00579748
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma
NCT00256269
UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling
NCT00355758
Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer
NCT00256308
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
NCT04039867
Does Antenatal Fetal Head Circumference Predict Anal Sphincter Injury, a Prospective Study
NCT00580879
Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma
NCT00256321
Telephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stages I, II, or III Cervical Cancer
NCT00086242
FloSeal Tubeless Exit Versus Cope Loop Nephrostomy Versus Fascial Stitch Following Percutaneous Nephrolithotripsy
NCT00360477
Evaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During Pregnancy
NCT00319176
Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
NCT00257348
Optical Clearing of the Skin in Conjunction With Laser Treatments
NCT00580736
Cutaneous Effects of Cryogen Spray Cooling
NCT00581568
Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma
NCT00257816
Trial of Ropinirole in Motor Recovery After Stroke
NCT00221390
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 46 |
| Phase 2 | 46 |
| Phase 3 | 6 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the University of California, Irvine pipeline
74 recruiting of 368 indexed (20% open); 228 completed (62%).
Phase mix: 27 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Irvine: open-pipeline peers nationwide
Peers matched on 368 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of California, Irvine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 368 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
- New York State Psychiatric Institute · 364 trials · 3% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of Miami · 20% recruiting · 721 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of California, Irvine page
368 registered trials is a research-attention snapshot, not an endorsement of University of California, Irvine or any single study.
- 74 of University of California, Irvine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of California, Irvine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Irvine pipeline card: 368 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.